Location: Home
  • search
  • go
  • Relate News
  • 9/6/2022China's Veteran Drugmakers Are Rushing into the Nucleic Acid Drug Race...
  • 9/6/2022'Still The Place To Do Drug Innovation': China Biotech CEO Podcast Wit...
  • 9/6/2022A Share-Listed Chinese Pharma Cos Report Performance in H1/2022
  • 9/6/2022KPMG Sued for $830M over Botched Audit of US-Listed China Medical Tech...
  • 9/6/2022CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
  • 9/6/2022NHSA Publicizes the List of Drugs Passing Preliminary Form Evaluation ...
  • 9/5/2022CDE Solicits Comments on Draft Technical Guidelines for Abuse Preventi...
  • 9/5/2022AZ's Forxiga Wins Approval in China for Kidney Disease with/without Ty...
  • 9/5/2022Asieris Acquires Rights to Heart Failure Therapy from Acorda
  • 9/5/2022CellOrigin Enter Strategic Global Collaboration with Qilu Pharma to D...
  • 9/5/2022Debt-Strapped Fosun Intl to Pare Stakes in Listed Subsidiaries Includi...
  • 9/2/2022PharmaLex Group Opens New Offices in China
  • 9/2/2022NHC: China Completes Initial Phase of National Health Information Plat...
  • 9/2/2022CNNIC: China's Internet Users Exceed 1.05B by June 2022 with 99.6% Bei...
  • 9/2/2022SAMR Issues New Regulation on Online Drug Sales (with Summary)
  • 9/2/2022Drug R&D and Product Registration News Digest September 2022 (1)
  • 9/2/2022Recent Official and Executive Moves
  • 9/2/2022Targeting Novo Nordisk in China's Obesity Market with A Unique Proposi...
  • 9/1/2022Why Genentech Eyes on Jemincare's Androgen Receptor Degrader?
  • 9/1/2022NMPA and Chinese Customs Announce Addition of Shijiazhuang Airport as ...
  • 8/31/2022Mayo Clinic, Hibiscus and Innoforce Announce Mayflower Cell and Gene T...
  • 8/31/2022Financial-related Company News Digest (August 2022)
  • 8/31/2022IQVIA: Chinese Hospital Drug Market Down 5.8% in Q2/2022
  • 8/31/2022Snapshot of Top Ten Drug Products by Representative Hospital Sales in ...
  • 8/31/2022BCG Report: Chinese Vaccine Sector under Restructure - Opportunities a...
  • 8/30/2022USCBC 2022 Member Survey: China's COVID-19 Policies Are the Top Chall...
  • 8/30/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (62...
  • 8/30/2022CDE Solicits Comments on Draft Technical Guidelines for Writing of Pha...
  • 8/30/2022RoosterBio and MBL Beijing Biotech Partner to Accelerate Advanced Ther...
  • 8/30/2022Noteworthy Drugs Expected To Be Approved in China in H2/2022 (PharmCub...
  • Page:128/774 Total number of articles:23207: [First][<<] [126] [127] [128] [129] [130] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group